News from MarketWatch Top Stories

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Tariffs Ceo Cryptocurrency Crypto Assets Stocks Investors Stock Stock Market Shares Ethereum Markets Price Xrp Blockchain Investment Sec Eth Etf Stablecoin Trade Earnings Revenue Solana China Index Coinbase Bse Token Nasdaq Usd Wall Street Ipo Trade War Interest Rates Inflation Economy Profit Digital Assets Nvidia Sensex Sp 500 Gold Binance Federal Reserve Treasury Nse Traders Price Targets Car Sales Strategic Defence Review Content Spending Indian Resources Dip Consumer Watchdog Wholesale Cbdc Private Lenders Bonus Round

Filter by:

Copd × Past week × MarketWatch Top Stories ×

MarketWatch Top Stories • May 30, 2025

Regeneron dashes Wall Street’s hopes as COPD treatment trial suffers a failure

The unsuccessful outcome of Regeneron’s advanced COPD therapy study led to a significant decline in its stock value, marking the company’s largest drop in over a decade on financia...

Read Full Article →